Bupropion - Naltrexone Bests Placebo in Methamphetamine Use Disorder
Response was low but higher with naltrexone - bupropion than placebo during 12 - week, two - stage trial (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - January 15, 2021 Category: Psychiatry Tags: Pharmacy, Psychiatry, Journal, Source Type: news
Bupropion-Naltrexone Bests Placebo in Methamphetamine Use Disorder
FRIDAY, Jan. 15, 2021 -- For adults with methamphetamine use disorder, response is higher with receipt of extended-release injectable naltrexone plus oral extended-release bupropion versus placebo, according to a study published in the Jan. 14 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 15, 2021 Category: Pharmaceuticals Source Type: news
Naltrexone and Bupropion Promising Combo for Meth Addiction Naltrexone and Bupropion Promising Combo for Meth Addiction
The combination treatment may be a game changer for some patients with severe methamphetamine use disorder, results of a new randomized trial, ADAPT-2, suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 14, 2021 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Relapse prevention interventions for smoking cessation
Updated review found that behavioural interventions provided no worthwhile benefit in preventing relapse in assisted abstainers. Moderate certainty evidence suggests that extended treatment with varenicline but not bupropion helped to prevent relapse. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 21, 2020 Category: Consumer Health News Source Type: news
Contrave Boosts Weight Loss in Diabetes Patients on Incretins Contrave Boosts Weight Loss in Diabetes Patients on Incretins
Naltrexone/bupropion added to a GLP-1 agonist or a DPP-4 inhibitor is a reasonable option for weight loss in patients with obesity and type 2 diabetes, a study suggests.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 30, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Antidepressant Fails to Improve Apathy in Dementia Patients Antidepressant Fails to Improve Apathy in Dementia Patients
The antidepressant bupropion was no better than placebo in reducing apathy in nondepressed patients with Alzheimer-type dementia in a randomized controlled trial.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - May 29, 2020 Category: Primary Care Tags: Psychiatry News Source Type: news
International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A
International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg tablets. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 20, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Serotonin toxicity from isolated bupropion overdoses - Sidlak AM, Koivisto KO, Marino RT, Abesamis MG.
Background: Bupropion is a synthetic cathinone, which acts therapeutically through norepinephrine and dopamine reuptake inhibition. Recent evidence suggests that serotonin receptor activation occurs with high doses of bupropion and severe serotonin ... (Source: SafetyLit)
Source: SafetyLit - April 21, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Buproprion associated seizures following acute overdose: who develops late seizures - Offerman S, Gosen J, Thomas SH, Padilla-Jones A, Ruha AM, Levine M.
Objectives: Bupropion is an antidepressant that is commonly known to cause seizures in overdose. Because of concern for delayed onset of seizures, patients are frequently observed for prolonged periods after overdose. The primary objective is to eva... (Source: SafetyLit)
Source: SafetyLit - March 30, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Wellbutrin (bupropion)
Title: Wellbutrin (bupropion)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/12/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 12, 2020 Category: Drugs & Pharmacology Source Type: news
Clinical characteristics and outcomes associated with bupropion overdose: a Canadian perspective - Stewart E, Grewal K, Hudson H, Thompson M, Godwin J.
Background: Therapeutic use, overdose and recreational abuse of bupropion are increasing. The purpose of this study was to describe the incidence and outcomes of bupropion exposures reported to the Ontario Poison Centre in Canada, and to identify pr... (Source: SafetyLit)
Source: SafetyLit - December 16, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Drug safety update: Naltrexone/bupropion (Mysimba)
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update that patients should be advised that naltrexone/bupropion has been associated with adverse reactions such (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 20, 2019 Category: Drugs & Pharmacology Source Type: news
